Ionis to present at upcoming investor conferences

Ionis Pharmaceuticals (Nasdaq: IONS) will present a company overview at several upcoming virtual investor conferences.

Rhea-AI Summary

Ionis Pharmaceuticals (Nasdaq: IONS) will present a company overview at several upcoming virtual investor conferences. Key dates include:

• June 1, 2021: William Blair 41st Annual Growth Stock Conference
• June 9, 2021: Goldman Sachs 42nd Annual Global Healthcare Conference
• June 15, 2021: Nasdaq 44th Investor Conference
• June 22, 2021: BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology

Live webcasts will be available on Ionis' website, with replays archived for a limited time.

Argus Session date unavailable

+0.68% session move Open Argus

Details

News Market Reaction – IONS

The recorded move for IONS in the trading session of this news was +0.68%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CARLSBAD, Calif., May 26, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will present a company overview at the following virtual investor conferences:

• William Blair 41^st Annual Growth Stock Conference on Tuesday, June 1, 2021
• Goldman Sachs 42^nd Annual Global Healthcare Conference on Wednesday, June 9, 2021
• Nasdaq 44^th Investor Conference on Tuesday, June 15, 2021
• BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology on Tuesday, June 22, 2021

The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company's website. Please check www.ionispharma.com for the latest information.

A live webcast of the presentations will be available on the Investors & Media section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies.

To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

View original content to download multimedia:http://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301299234.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What investor conferences is Ionis Pharmaceuticals participating in June 2021?

Ionis Pharmaceuticals will participate in the William Blair Growth Stock Conference on June 1, Goldman Sachs Healthcare Conference on June 9, Nasdaq Investor Conference on June 15, and BMO Biopharma Day on June 22.

Where can I watch Ionis Pharmaceuticals' investor presentations?

You can watch Ionis Pharmaceuticals' live presentations on their Investors & Media section of the website, with replays available within 48 hours.

What is the focus of Ionis Pharmaceuticals' presentations in June 2021?

Ionis Pharmaceuticals will provide a company overview, discussing their RNA-targeted therapies and late-stage pipeline during the investor conferences.

When will the investor presentations by Ionis Pharmaceuticals take place?

The presentations will occur on June 1, June 9, June 15, and June 22, 2021.